PAVmed (PAVM) Total Debt Growth (1y) (2018 - 2025)
PAVmed (PAVM) Total Debt Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 19.06% |
| 10 | PAVmed | 11.39 Mn | 9.86 Mn | -4,000.00 | -61.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61.86% |
| Jun 30, 2025 | -84.55% |
| Mar 31, 2025 | -85.51% |
| Dec 31, 2024 | -34.16% |
| Jun 30, 2024 | 2.35% |
| Mar 31, 2024 | 2.80% |
| Dec 31, 2023 | 31.35% |
| Sep 30, 2023 | 26.73% |
| Jun 30, 2023 | 45.73% |
| Dec 31, 2020 | -71.74% |
| Sep 30, 2020 | 5.11% |
| Jun 30, 2020 | 319.73% |
| Mar 31, 2020 | 150.67% |
| Dec 31, 2019 | 105.97% |
| Sep 30, 2019 | 37.33% |
| Jun 30, 2019 | 146.89% |
| Mar 31, 2019 | 266.72% |
| Dec 31, 2018 | 306.48% |
| Sep 30, 2018 | 105.73% |